BG Medicine, Inc. - FORM S-1/A - EX-23.1 - CONSENT OF DELOITTE & TOUCHE, LLP - August 31, 2010

Attached files

file filename
S-1/A - FORM S-1 AMENDMENT #3 - BG Medicine, Inc.ds1a.htm
EX-4.8 - FORM OF 2010 COMMON STOCK BRIDGE WARRANT - BG Medicine, Inc.dex48.htm
EX-4.9 - SECURITIES PURCHASE AGREEMENT - BG Medicine, Inc.dex49.htm
EX-3.2 - FORM OF RESTATED CERTIFICATE OF INCORPORATION - BG Medicine, Inc.dex32.htm
EX-3.4 - FORM OF RESTATED BYLAWS - BG Medicine, Inc.dex34.htm
EX-23.3 - CONSENT OF KALORAMA INFORMATION - BG Medicine, Inc.dex233.htm
EX-4.10 - FORM OF CONVERTIBLE PROMISSORY NOTE - BG Medicine, Inc.dex410.htm
EX-10.4 - LICENSE & DISTRIBUTION AGREEMENT - BG Medicine, Inc.dex104.htm
EX-10.21 - FORM OF INDEMNIFICATION AGREEMENT - BG Medicine, Inc.dex1021.htm
EX-10.3.3 - THIRD LOAN MODIFICATION AGREEMENT - BG Medicine, Inc.dex1033.htm
EX-10.3.1 - FIRST LOAN MODIFICATION AGREEMENT - BG Medicine, Inc.dex1031.htm
EX-10.29 - NON- EMPLOYEE DIRECTOR COMPENSATION POLICY - BG Medicine, Inc.dex1029.htm
EX-10.27 - FORM OF RESTRICTED STOCK AGREEMENT - BG Medicine, Inc.dex1027.htm
EX-10.14 - LICENSE AND SUPPLY AGREEMENT - BG Medicine, Inc.dex1014.htm
EX-10.28 - 2010 EMPLOYEE STOCK PURCHASE PLAN - BG Medicine, Inc.dex1028.htm
EX-10.26 - FORM OF STOCK OPTION AGREEMENT - BG Medicine, Inc.dex1026.htm
EX-10.25 - 2010 EMPLOYEE, DIRECTOR AND CONSULTANT STOCK PLAN - BG Medicine, Inc.dex1025.htm

Exhibit 23.1

CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

We consent to the use in this Amendment No. 3 to Registration Statement No. 333-164574 of our report dated January 28, 2010 relating to the consolidated financial statements of BG Medicine, Inc. and subsidiary (which report expresses an unqualified opinion and includes an explanatory paragraph relating to substantial doubt about the company’s ability to continue as a going concern) appearing in the Prospectus, which is part of such Registration Statement. We also consent to the reference to us under the heading “Experts” in such Prospectus.

/s/ Deloitte & Touche LLP

Boston, Massachusetts

August 30, 2010    

BG Medicine, Inc. Reports